|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.545
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.373
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.371
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.359
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.356
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.237
|
|
|
rna processing
|
GO:0006396 |
105 |
0.176
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.143
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.134
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.132
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.132
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.131
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.129
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.114
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
1 |
0.101
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.097
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.094
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.090
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.088
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.085
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.083
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.075
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.074
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.067
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.066
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.065
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.063
|
|
|
regionalization
|
GO:0003002 |
337 |
0.062
|
Mouse |
|
gonad development
|
GO:0008406 |
141 |
0.057
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.055
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.055
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.054
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.052
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.052
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.050
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.050
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.050
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.050
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.049
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.047
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.046
|
|
|
protein refolding
|
GO:0042026 |
1 |
0.046
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.045
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.045
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.044
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.040
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.040
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.040
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.040
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.039
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.039
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.038
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.037
|
|
|
translation
|
GO:0006412 |
93 |
0.037
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.037
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.037
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.036
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.036
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.036
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.035
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.034
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.034
|
|
|
3 utr mediated mrna stabilization
|
GO:0070935 |
2 |
0.034
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.033
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.032
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.032
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.031
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.031
|
|
|
cell division
|
GO:0051301 |
120 |
0.031
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.030
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.029
|
|
|
response to heat
|
GO:0009408 |
27 |
0.029
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.029
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.029
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.027
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.027
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.026
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.026
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.026
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.026
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.025
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.024
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.024
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.024
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.023
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.022
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
Worm |
|
macromolecule methylation
|
GO:0043414 |
120 |
0.022
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.022
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.022
|
|
|
skin development
|
GO:0043588 |
220 |
0.021
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.021
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.020
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.020
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.020
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.019
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.019
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
rna interference
|
GO:0016246 |
2 |
0.019
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.018
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.018
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.018
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.017
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.017
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
intraciliary transport
|
GO:0042073 |
9 |
0.017
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.017
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.017
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.017
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.017
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.016
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.016
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.016
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.016
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.016
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.016
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.016
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.015
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.015
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.015
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
gland development
|
GO:0048732 |
330 |
0.015
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.015
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.015
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.014
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.014
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.014
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.014
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.014
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.014
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.014
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.014
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.014
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.014
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.013
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.013
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.013
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.013
|
|
|
histone modification
|
GO:0016570 |
159 |
0.013
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.013
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.013
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.012
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.012
|
|
|
translesion synthesis
|
GO:0019985 |
1 |
0.012
|
|
|
negative regulation of mrna splicing via spliceosome
|
GO:0048025 |
12 |
0.012
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.012
|
|
|
regulation of rna stability
|
GO:0043487 |
26 |
0.012
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.012
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.012
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.012
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.012
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.012
|
|
|
primary mirna processing
|
GO:0031053 |
1 |
0.012
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.012
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.012
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.012
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.011
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.011
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.011
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.011
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.011
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.011
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.011
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.011
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.011
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.011
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.011
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.011
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.011
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.011
|
|
|
response to drug
|
GO:0042493 |
75 |
0.011
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.011
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.011
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.011
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.011
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.011
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.011
|
|
|
spliceosomal complex assembly
|
GO:0000245 |
6 |
0.011
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.011
|
|
|
dna repair
|
GO:0006281 |
107 |
0.010
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.010
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.010
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.010
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.010
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.010
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.010
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.010
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.010
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.010
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.010
|
|
|
cellularization
|
GO:0007349 |
1 |
0.010
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.010
|
|
|
methylation
|
GO:0032259 |
134 |
0.010
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.010
|
|